dendritic cell-gp100-MART-1 antigen vaccine
Term · Oncology and biomedicine · MLC-T-ONC-012966
An autologous dendritic cell vaccine with antineoplastic property. Dendritic cells harvested from cancer patients are pulsed with human gp100 melanoma antigen and MART-1 antigen (a melanoma antigen recognized by T-cells); both antigens are up-regulated in melanomas. Vaccination with this vaccine may elicit the host immune response against MART-1 or gp100 expressing cells.
| Identifier | MLC-T-ONC-012966 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | DC-gp100-MART-1 |
| Synonyms | gp100/Mart-1-transduced dendritic cell vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012966",
"term": "dendritic cell-gp100-MART-1 antigen vaccine",
"field": "Oncology and biomedicine",
"definition": "An autologous dendritic cell vaccine with antineoplastic property. Dendritic cells harvested from cancer patients are pulsed with human gp100 melanoma antigen and MART-1 antigen (a melanoma antigen recognized by T-cells); both antigens are up-regulated in melanomas. Vaccination with this vaccine may elicit the host immune response against MART-1 or gp100 expressing cells.",
"abbreviation": "DC-gp100-MART-1",
"synonyms": [
"gp100/Mart-1-transduced dendritic cell vaccine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/dendritic-cell-gp100-mart-1-antigen-vaccine/"
}
Record 5,810 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.